Volume 19 (2010)

Get Adobe ReaderSome of the documents on this page are in Adobe PDF format. To view these files you will need the free Adobe Reader. Download Adobe Reader(external link)

Return to volumes listing

Number Date Topics Covered
15 December2010(document, opens in a new window)(287KB)
  • Specially prepared medicines – Branded prescribing
  • QRISK 2
  • Prednisolone EC tabs
  • Medicines storage
14 December2010(document, opens in a new window)(116 KB)
  • Safer administration of Insulin
  • Azathioprine / allopurinol interaction
  • Methotrexate 10mg tablets
  • Diclofenac 3% gel
  • Warfarin and antimicrobial interactions
13 October2010(document, opens in a new window)(104 KB)
  • Clostridium difficile infection
  • Pneumonia; fractures; rebound acid hypersecretion
  • Cardiovascular risk
12 September2010(document, opens in a new window)(222 KB)updated August 2012
  • Guidelines for Management of Acute Diarrhoea in Primary Care
  • When to send a stool sample
  • Routinely laboratory tests and tests that must be specifically requested
  • When should more than one specimen be sent?
  • What clinical details to include in the electronic request
  • Management points
  • Clostridium Difficile Infection Summary
  • What to consider hospital referral
  • Flow chart guidelines for investigation of Acute Diarrhoea in the Community
  • Collecting a stool specimen for microbiological examination
11 September2010-2(document, opens in a new window)
(104 KB)
  • Key Messages in Cardiovascular Prescribing
  • Renin-Angiotensin System Drugs
  • Ezetemibe use in Statin Intolerance Clopidogrel and Proton Pump Inhibitors
  • Clopidogrel & PPIs
10 Septemmber2010-3(document, opens in a new window)
(71 KB)
  • Safer Lithium Therapy and Care Home Use of Medicines Study
  • Safer Lithium Therapy
  • Shared Care Responsibilities
  • Care Home Use of Medicines Study (CHUMS)
  • Best Practice for prescribing, dispensing and monitoring of medication in Care Homes
09 August2010(document, opens in a new window)
(106 KB)
  • Calciums supplements & links to MI
  • Areas for potential cost-savings
  • Quetiapine MR
  • Locally agreed neuropathic pain guidance – comparison with NICE CG96
  • Specially prepared eye drops
08 August2010-2(document, opens in a new window)
(46 KB)
  • Patients at High Risk of Infective Endocarditis
  • Congenital Heart Disease
  • When not to give Infective Endocarditis Prophylaxis
  • Dental Procedures
  • Antibacterial Prophylaxis
  • Identification of Patients Requiring Antibacterial Prophylaxis
07 May2010(document, opens in a new window)(169 KB)
  • Undernutrition guidelines for Primary care; food first approach
  • Prescribing Oral Nutritional Supplements
  • NICE CG101; 2010 Chronic obstructive pulmonary disease
  • ARBs and cancer risk
  • Tamoxifen interactions with medications that inhibit CYP2D6
06 July2010(document, opens in a new window)(55 KB)
  • Safety in Doses – Improving the Use of Medicines in the NHS
  • Care Homes’ Use of Medicines Study: prevalence, causes and potential harm of medication errors in care homes for older people
  • PCT Error Reporting Process
  • Being Open – Communicating with patients, their families and carers following a patient safety incident
05 June2010(document, opens in a new window)(182 KB)
  • Respiratory Medicine
04 April2010 (document, opens in a new window)
(116 KB)
  • CFC containing beclomethasone inhalersdiscontinued
  • Exenatide pre-filled injection (Byetta)
  • Management of Chronic Constipation
  • Silver Dressings – Inadequate Evidence to Support Use
  • EllaOne
  • Prednisolone tablets
03 March2010(document, opens in a new window)updated August 2012
(123 KB)
  • MRSA
02 February2010(document, opens in a new window)
(62 KB)
  • Liquid Specials
  • Rosemont products
  • Antimicrobial dosage in children
  • EllaOne for emergency contraception
01 January2010(document, opens in a new window)
(124 KB)
  • Sibutramine cardiovascular concerns
  • FDA requests new safety studies on exenatide
  • Diuretics as first line treatment of hypertension
  • Heart failure benefits of statins
  • Good practice monitoring guidelines for severemental illness patients
  • Tacrolimus – importance of branded prescribing
  • Prescriptions for seven days; Q and As
  • PCT commissioned MDS service
  • Changes to Rifinah packaging
  • Safer lithium therapy

Return to volumes listing

Copyright 2017 © Oxfordshire Clinical Commissioning Group